Andrea Biondo

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors

L. Rhoda Molife, Yan Li, Joanna Vitfell-Rasmussen et al. · Journal of Hematology & Oncology · 2014 · 190 citations · Full text

Medicine, Oncology, Pharmacology +17

Interrogating Two Schedules of the AKT Inhibitor MK-2206 in Patients with Advanced Solid Tumors Incorporating Novel Pharmacodynamic and Functional Imaging Biomarkers

Timothy A. Yap, Yan Li, Amita Patnaik et al. · Clinical Cancer Research · 2014 · 79 citations

Medicine, Oncology, Pharmacology +17

Baseline chest X-ray in coronavirus disease 19 (COVID-19) patients: association with clinical and laboratory data

Marco Gatti, Marco Calandri, Matteo Barba et al. · La radiologia medica · 2020 · 49 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

A randomized comparison of endometrial laser intrauterine thermotherapy and hysteroscopic endometrial resection

Antonio Castelli, Gaspare Cucinella, Andrea Biondo et al. · Fertility and Sterility · 2004 · 46 citations · Full text

Medicine, Gynecology, Surgery +8

A phase I study evaluating GDC-0941, an oral phosphoinositide-3 kinase (PI3K) inhibitor, in patients with advanced solid tumors or multiple myeloma.

Richard D. Baird, Kinjal Shah, Bristi Basu et al. · Journal of Clinical Oncology · 2011 · 39 citations

Medicine, Oncology, Pharmacology +17